Agape ATP Corp reports executive changes, new compensation on 1/2/24

Ticker: ATPC · Form: 8-K · Filed: Jan 2, 2024 · CIK: 1713210

Agape Atp Corp 8-K Filing Summary
FieldDetail
CompanyAgape Atp Corp (ATPC)
Form Type8-K
Filed DateJan 2, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001, $0, $400,000
Sentimentmixed

Complexity: simple

Sentiment: mixed

Topics: executive-change, compensation, corporate-governance

TL;DR

**Agape ATP Corp just shook up its leadership and pay, watch for strategic shifts.**

AI Summary

Agape ATP Corp filed an 8-K on January 2, 2024, reporting a significant change in its executive leadership and compensation structure, effective December 28, 2023. The filing indicates a 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.' This matters to investors because changes in key leadership and their compensation can signal shifts in company strategy, financial health, or governance, potentially impacting future stock performance.

Why It Matters

Changes in executive leadership and compensation can signal strategic shifts or financial adjustments within Agape ATP Corp, directly influencing investor confidence and the company's future direction.

Risk Assessment

Risk Level: medium — Changes in executive leadership can introduce uncertainty regarding future company strategy and performance, warranting a medium risk assessment.

Analyst Insight

Investors should monitor subsequent filings or company announcements for specific details regarding the new leadership and compensation structures, as these will provide clearer insights into the company's strategic direction and potential financial implications.

Key Players & Entities

  • Agape ATP Corp (company) — the registrant filing the 8-K
  • January 2, 2024 (date) — date of the 8-K filing
  • December 28, 2023 (date) — date of the earliest event reported in the 8-K

Forward-Looking Statements

  • Agape ATP Corp will announce specific names of new officers and directors, and details of compensatory arrangements. (Agape ATP Corp) — medium confidence, target: Q1 2024

FAQ

What specific events are reported in this 8-K filing by Agape ATP Corp?

The 8-K filing by Agape ATP Corp reports 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' and 'Financial Statements and Exhibits'.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on December 28, 2023.

What is the filing date of this 8-K for Agape ATP Corp?

The filing date of this 8-K for Agape ATP Corp is January 2, 2024.

What is Agape ATP Corp's business address as listed in the filing?

Agape ATP Corp's business address is 1705 – 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia, Taman Desa, Kuala Lumpur, Malaysia 58100.

What is the Central Index Key (CIK) for Agape ATP Corp?

The Central Index Key (CIK) for Agape ATP Corp is 0001713210.

Filing Stats: 585 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-01-02 16:05:40

Key Financial Figures

  • $0.0001 — ch registered Common Stock, par value $0.0001 per share ATPC NASDAQ Capital Marke
  • $0 — r. How, which originally consisted of US$0 pursuant to the original Employment Agr
  • $400,000 — "Original Agreement"), be amended to US$400,000 per annum. Except as specifically amend

Filing Documents

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 2, 2024 (December 28, 2023 ) AGAPE ATP CORPORATION (Exact name of registrant as specified in its charter) Nevada 001-41835 36-4838886 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 1705 – 1708, Level 17, Tower 2, Faber Towers , Jalan Desa Bahagia , Taman Desa , Kuala Lumpur , Malaysia 58100 (Address of principal executive offices) (Zip Code) +(60) 192230099 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share ATPC NASDAQ Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging Growth Company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers Dr. How Kok Choong On December 28, 2023, the Company entered into an Amendment to Executive Director Agreement (the "Amendment Agreement") with Dr. How Kok Choong ("Dr. How"), chief executive officer, president chief operating officer and executive director of the Company, pursuant to which the compensation of Dr. How, which originally consisted of US$0 pursuant to the original Employment Agreement for Executive Director entered into between the Company and Dr. How dated June 1, 2016 (the "Original Agreement"), be amended to US$400,000 per annum. Except as specifically amended in the Amendment Agreement, all other terms and conditions of the Original Agreement remains in full force and effect. The foregoing is only a brief description of the material terms of the Amendment Agreement, and is qualified in its entirety by reference to such exhibit. A form of the Original Agreement is incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. c) Exhibits 99.1* Form of Executive Director Agreement with Dr. How Kok Choong 99.2 Form of Amendment to Executive Director Agreement with Dr. How Kok Choong 104 Cover Page Interactive Data File (embedded within the inline XBRL Document). * Previously filed 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AGAPE ATP CORPORATION Date: January 2, 2024 By: /s/ How Kok Choong Name: How Kok Choong Title: Chief Executive Officer, President, Director, Secretary and Treasurer (Principal Executive Officer) 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.